These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15964938)

  • 21. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,3-diaminopropan-2-ol sulfonamides as potent and selective inhibitors of the glycine transporter type 1.
    Rahman SS; Coulton S; Herdon HJ; Joiner GF; Jin J; Porter RA
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1741-5. PubMed ID: 17234406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro screening strategies for nicotinic receptor ligands.
    Dunlop J; Roncarati R; Jow B; Bothmann H; Lock T; Kowal D; Bowlby M; Terstappen GC
    Biochem Pharmacol; 2007 Oct; 74(8):1172-81. PubMed ID: 17706607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors.
    Li H; Black PN; DiRusso CC
    Anal Biochem; 2005 Jan; 336(1):11-9. PubMed ID: 15582553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptors.
    Sidach SS; Fedorov NB; Lippiello PM; Bencherif M
    J Neurosci Methods; 2009 Aug; 182(1):17-24. PubMed ID: 19481112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a cell-based high-throughput screening assay for TRPM2 channel modulators.
    Song Y; Buelow B; Perraud AL; Scharenberg AM
    J Biomol Screen; 2008 Jan; 13(1):54-61. PubMed ID: 18057180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.
    Martina M; Gorfinkel Y; Halman S; Lowe JA; Periyalwar P; Schmidt CJ; Bergeron R
    J Physiol; 2004 Jun; 557(Pt 2):489-500. PubMed ID: 15064326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra.
    Wagstaff R; Hedrick M; Fan J; Crowe PD; DiSepio D
    J Biomol Screen; 2007 Apr; 12(3):436-41. PubMed ID: 17438071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors.
    Ho KK; Appell KC; Baldwin JJ; Bohnstedt AC; Dong G; Guo T; Horlick R; Islam KR; Kultgen SG; Masterson CM; McDonald E; McMillan K; Morphy JR; Rankovic Z; Sundaram H; Webb M
    Bioorg Med Chem Lett; 2004 Jan; 14(2):545-8. PubMed ID: 14698200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Characterization of Inhibitors of a Neutral Amino Acid Transporter, SLC6A19, Using Two Functional Cell-Based Assays.
    Danthi SJ; Liang B; Smicker O; Coupland B; Gregory J; Gefteas E; Tietz D; Klodnitsky H; Randall K; Belanger A; Kuntzweiler TA
    SLAS Discov; 2019 Feb; 24(2):111-120. PubMed ID: 30589598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring Ca²⁺ changes in multiwell format using the Fluorometric Imaging Plate Reader (FLIPR(®)).
    Marshall IC; Owen DE; McNulty S
    Methods Mol Biol; 2013; 937():103-9. PubMed ID: 23007581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene.
    Borowsky B; Mezey E; Hoffman BJ
    Neuron; 1993 May; 10(5):851-63. PubMed ID: 8494645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The discovery of potent glycine transporter type-2 inhibitors: design and synthesis of phenoxymethylbenzamide derivatives.
    Takahashi E; Arai T; Akahira M; Nakajima M; Nishimura K; Omori Y; Kumagai H; Suzuki T; Hayashi R
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4603-4606. PubMed ID: 25176190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first potent and selective inhibitors of the glycine transporter type 2.
    Caulfield WL; Collie IT; Dickins RS; Epemolu O; McGuire R; Hill DR; McVey G; Morphy JR; Rankovic Z; Sundaram H
    J Med Chem; 2001 Aug; 44(17):2679-82. PubMed ID: 11495577
    [No Abstract]   [Full Text] [Related]  

  • 39. A Solid Supported Membrane-Based Technology for Electrophysical Screening of B
    Gerbeth-Kreul C; Pommereau A; Ruf S; Kane JL; Kuntzweiler T; Hessler G; Engel CK; Shum P; Wei L; Czech J; Licher T
    SLAS Discov; 2021 Jul; 26(6):783-797. PubMed ID: 33955247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital Imaging as a Detection Method for a Fluorescent Protease Assay in 96-Well and Miniaturized Assay Plate Formats.
    Abriola L; Chin M; Fuerst P; Schweitzer R; Sills MA
    J Biomol Screen; 1999; 4(3):121-127. PubMed ID: 10838420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.